The Pfizer COVID-19 vaccine was one of multiple vaccines which was used to battle the coronavirus global epidemic ...

AstraZeneca is withdrawing its corona vaccine Vaxzevria worldwide.

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

The U.S. CDC plans to embark on a large study into potential connections between vaccines and autism, despite extensive scientific research ...

Lehigh County Courthouse staffer Adam Young sits with his face shield on as a juror would during a video shoot at the ...

A CJEU copyright decision on employees' rights and an update on an IP feud concerning foreign rights over 'Superman' were ...

According to Halozyme, the new version of Keytruda infringes on its patents, the report said. USAID cuts put tuberculosis response in peril, WHO says The Trump administration's decision to pause U.S.

Environmental Health Technician Shatesase Bland and On Site Wastewater Supervisor James Tiger spoke with Andrew Stuckey on Wednesday, March 5.

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...

If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per violation.